These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 9835313)

  • 1. Surveillance in Barrett's oesophagus: a need for reassessment?
    Nandurkar S; Talley NJ
    J Gastroenterol Hepatol; 1998 Oct; 13(10):990-6. PubMed ID: 9835313
    [No Abstract]   [Full Text] [Related]  

  • 2. Increasing incidence of Barrett's oesophagus: education, enthusiasm, or epidemiology?
    Prach AT; MacDonald TA; Hopwood DA; Johnston DA
    Lancet; 1997 Sep; 350(9082):933. PubMed ID: 9314878
    [No Abstract]   [Full Text] [Related]  

  • 3. Barrett's esophagus surveillance in Asians.
    Rajendra S; Kutty KM
    J Clin Gastroenterol; 2009; 43(10):1013-4. PubMed ID: 19564791
    [No Abstract]   [Full Text] [Related]  

  • 4. Oesophageal adenocarcinoma and Barrett's oesophagus.
    Das M
    Lancet Oncol; 2016 Dec; 17(12):e524. PubMed ID: 27818151
    [No Abstract]   [Full Text] [Related]  

  • 5. Incidence of adenocarcinoma and mortality in patients with Barrett's oesophagus diagnosed between 1976 and 1986: implications for endoscopic surveillance.
    Rana PS; Johnston DA
    Dis Esophagus; 2000; 13(1):28-31. PubMed ID: 11005328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surveillance for Barrett's oesophagus: results from a programme in Northern Ireland.
    Murphy SJ; Dickey W; Hughes D; O'Connor FA
    Eur J Gastroenterol Hepatol; 2005 Oct; 17(10):1029-35. PubMed ID: 16148547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of malignant progression in patients with Barrett's oesophagus: a Dutch nationwide cohort study.
    de Jonge PJ; van Blankenstein M; Looman CW; Casparie MK; Meijer GA; Kuipers EJ
    Gut; 2010 Aug; 59(8):1030-6. PubMed ID: 20639249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Who Deserves Endoscopic Screening for Esophageal Neoplasia?
    Blevins CH; Iyer PG
    Gastrointest Endosc Clin N Am; 2017 Jul; 27(3):365-378. PubMed ID: 28577762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endoscopic features of Barrett's esophagus. G.O.S.P.E. Gruppo Operativo per lo Studio delle Precancerosi Esofagee.
    Conio M
    Endoscopy; 1993 Nov; 25(9):642-4. PubMed ID: 8119222
    [No Abstract]   [Full Text] [Related]  

  • 10. Barrett's esophagus: A historical perspective, an update on core practicalities and predictions on future evolutions of management.
    Dent J
    J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():11-30. PubMed ID: 21199510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Barrett's oesophagus: Current controversies.
    Amadi C; Gatenby P
    World J Gastroenterol; 2017 Jul; 23(28):5051-5067. PubMed ID: 28811703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and Validation of a Model to Determine Risk of Progression of Barrett's Esophagus to Neoplasia.
    Parasa S; Vennalaganti S; Gaddam S; Vennalaganti P; Young P; Gupta N; Thota P; Cash B; Mathur S; Sampliner R; Moawad F; Lieberman D; Bansal A; Kennedy KF; Vargo J; Falk G; Spaander M; Bruno M; Sharma P
    Gastroenterology; 2018 Apr; 154(5):1282-1289.e2. PubMed ID: 29273452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Revision needed of follow-up policy for Barrett's esophagus].
    Giard RW; Coebergh JW; Ouwendijk RJ
    Ned Tijdschr Geneeskd; 2002 Jan; 146(4):150-4. PubMed ID: 11845562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The incidence of adenocarcinoma and dysplasia in Barrett's esophagus: report on the Cleveland Clinic Barrett's Esophagus Registry.
    O'Connor JB; Falk GW; Richter JE
    Am J Gastroenterol; 1999 Aug; 94(8):2037-42. PubMed ID: 10445525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Barrett's esophagus: clinical characteristics.
    Reynolds JC; Rahimi P; Hirschl D
    Gastroenterol Clin North Am; 2002 Jun; 31(2):441-60. PubMed ID: 12134612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Why Has Screening and Surveillance for Barrett's Esophagus Fallen Short in Stemming the Rising Incidence of Esophageal Adenocarcinoma?
    Spechler SJ; El-Serag HB
    Am J Gastroenterol; 2023 Apr; 118(4):590-592. PubMed ID: 36728873
    [No Abstract]   [Full Text] [Related]  

  • 17. Endoscopic surveillance of Barrett's esophagus: another viewpoint.
    Richter JE
    Am J Gastroenterol; 1993 May; 88(5):630-2. PubMed ID: 8480722
    [No Abstract]   [Full Text] [Related]  

  • 18. Effectiveness and Cost-Effectiveness of Endoscopic Screening and Surveillance.
    Saxena N; Inadomi JM
    Gastrointest Endosc Clin N Am; 2017 Jul; 27(3):397-421. PubMed ID: 28577764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Adenocarcinoma in Barrett's esophagus. A retrospective study of 46 patients followed during 3.5 years].
    Bujanda Fernández de Piérola L; Muñoz Villafranca C; Sánchez Martínez A; Iriondo Martínez de Luco C; Aras Portilla LM
    An Med Interna; 1999 Apr; 16(4):178-80. PubMed ID: 10339842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Esophagoscopic monitoring of Barrett's esophagus--additional life years of good quality or wasting of limited resources?].
    Voutilainen M
    Duodecim; 2010; 126(5):507-14. PubMed ID: 20597303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.